RLMD
Relmada Therapeutics, Inc. · Healthcare
CFO Maged Shenouda sold $96K of Relmada Therapeutics, Inc.
Sold$95,778
$31.93Price
3,000Shares
−57%Stake
What RLMD did after the filing
- The stock from Fri, Jan 29 close, $32.68
- +7.9%
- S&P 500, same days
- +7.1%
Measured over 30 trading days, to the Mar 15 close.
Traded Wed, Jan 27. Filed Fri, Jan 29, 12:24 PM ET, during the session. Returns use the Jan 29 close and the Mar 15 close. Not investment advice.